#cabozantinib
#cabozantinib

[ follow ]

Combination Treatment May Slow Disease Progression in Advanced Sarcoma - News Center

Cabozantinib plus temozolomide, given orally, showed potential to slow progression of advanced leiomyosarcoma and merits further clinical evaluation.

Exelixis is laying off 130 employees, about 11% of its workforce, and closing its Pennsylvania office to consolidate operations in Alameda.

[ Load more ]